Attachment as a predictor of dropout in mentalization‐based treatment
Psychology and Psychotherapy: Theory, Research and Practice · 2024
DOI: 10.1111/papt.12478 ↗At a glance
Randomisierte kontrollierte Studie in Psychology and Psychotherapy: Theory, Research and Practice, 2024. Written by Melissa G A Remeeus and 4 co-authors. Institution: Viersprong Institute for Studies on Personality Disorders, Bergen op Zoom, The Netherlands. Major MEDLINE topics: Patient Dropouts, Object Attachment, Borderline Personality Disorder, Mentalization. Cited 5 times so far (Crossref); 53 references. Funded by: ZonMw.
Abstract (original language)
Objectives
Although treatments of patients with borderline personality disorder (BPD) were historically associated with relatively high dropout rates, dropout rates in contemporary evidence‐based treatments for BPD are typically substantially lower. However, only a few studies have investigated dropout rates in mentalization‐based treatment (MBT), and even fewer have investigated predictors of dropout in this type of treatment. In this study, we investigated dropout rates in two types of MBT (day hospital MBT [MBT‐DH] and intensive outpatient MBT [MBT‐IOP]) using data from a recent multicenter randomized clinical trial. Given the central importance of attachment considerations in MBT, we also investigated the relationship between dropout in these two treatments and attachment dimensions.
Design
Within a multicenter randomized clinical trial, 114 BPD patients were randomized to MBT‐DH ( n = 70) or MBT‐IOP ( n = 44).
Methods
Dropout in both types of MBT was investigated using descriptive analyses, and its association with attachment anxiety and attachment avoidance, as measured by the Experiences in Close Relationships questionnaire at baseline, was investigated using regression analyses.
Results
Dropout rates were relatively low (10.5% across both types of MBT) and did not significantly differ between groups (11.4% in MBT‐DH, 9.1% in MBT‐IOP). Attachment avoidance and attachment anxiety did not impact dropout, nor did their interaction or the interaction with the type of MBT.
Conclusions
Low dropout rates in both types of MBT indicate a high level of engagement of patients in both programmes. Attachment dimensions were not associated with dropout, consistent with the principle that MBT is tailored to each individual's needs. More research is needed, however, to investigate to what extent attachment is a dynamic context‐bound adaptive process rather than a static personality feature.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Viersprong Institute for Studies on Personality Disorders, Bergen op Zoom, The Netherlands.
- Behavioural Science Institute, Radboud University, Nijmegen, The Netherlands.
- Department of Medical Psychology and Psychotherapy, Erasmus MC, Rotterdam, The Netherlands.
- Department of Medical Psychology, Maasstad Ziekenhuis, Rotterdam, The Netherlands.
- Faculty of Psychology and Educational Sciences, University of Leuven, Leuven, Belgium.
- Research Department of Clinical, Educational, and Health Psychology, University College London, London, UK.
ORCID profiles: Melissa G A Remeeus, Maaike L Smits, Dine J Feenstra, Patrick Luyten
Funding
- ZonMw
Cite
APA
Remeeus, M. G. A., Smits, M. L., Bal-Bax, A. M., Feenstra, D. J., & Luyten, P. (2024). Attachment as a predictor of dropout in mentalization‐based treatment. Psychology and Psychotherapy: Theory, Research and Practice. https://doi.org/10.1111/papt.12478
Vancouver
Remeeus MGA, Smits ML, Bal-Bax AM, Feenstra DJ, Luyten P. Attachment as a predictor of dropout in mentalization‐based treatment. Psychology and Psychotherapy: Theory, Research and Practice. 2024. doi:10.1111/papt.12478
BibTeX
@article{Remeeus2024,
author = {Remeeus, Melissa G A and Smits, Maaike L and Bal-Bax, Anna M and Feenstra, Dine J and Luyten, Patrick},
title = {Attachment as a predictor of dropout in mentalization‐based treatment},
journal = {Psychology and Psychotherapy: Theory, Research and Practice},
year = {2024},
doi = {10.1111/papt.12478}
}
EUVIMED